CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $236,518 | +16.5% | 4,213 | +35.3% | 0.09% | -16.5% |
Q3 2022 | $203,000 | -34.9% | 3,113 | -24.3% | 0.10% | -2.8% |
Q4 2021 | $312,000 | -10.1% | 4,113 | +32.5% | 0.11% | -22.1% |
Q3 2021 | $347,000 | -30.0% | 3,103 | +1.3% | 0.14% | -27.7% |
Q2 2021 | $496,000 | +33.0% | 3,063 | 0.0% | 0.19% | +24.5% |
Q1 2021 | $373,000 | -18.7% | 3,063 | +2.1% | 0.15% | -22.2% |
Q4 2020 | $459,000 | +92.9% | 3,000 | +5.3% | 0.19% | +59.0% |
Q3 2020 | $238,000 | – | 2,850 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |